autologous hematopoietic stem cell transplant (HSCT)

March 15, 2017

Kiadis to Present Promising Data from T-cell Therapy for Stem Cell Transplants in Patients with Blood Disorders

News

Patients undergoing allogeneic (donor) stem cell transplants may benefit from treatment with ATIR101, a form of T-cells that help to fight infections and tumor cells while the patient is recovering ... Read more

October 18, 2016

EMA Panel Recommends Opdivo’s European Approval for Classical Hodgkin’s Lymphoma

News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of Opdivo (nivolumab) for the treatment of classical Hodgkin’s lymphoma (cHL) in patients who relapsed or progressed ... Read more